首页 | 官方网站   微博 | 高级检索  
     

阿苯达唑-聚乙二醇6000固体分散体壳聚糖微球的制备与药剂学性质研究
引用本文:王晓青,刘扬,陈袁兰,朱爱军,张光宇,张学农,任伟新,迪理木拉提·巴吾东,顾俊鹏,许晓东.阿苯达唑-聚乙二醇6000固体分散体壳聚糖微球的制备与药剂学性质研究[J].中国药房,2012(5):424-427.
作者姓名:王晓青  刘扬  陈袁兰  朱爱军  张光宇  张学农  任伟新  迪理木拉提·巴吾东  顾俊鹏  许晓东
作者单位:苏州大学医学部药学院;新疆医科大学附属第一医院
基金项目:国家自然科学基金资助项目(30960102)
摘    要:目的:制备阿苯达唑-聚乙二醇6000(PEG)固体分散体壳聚糖微球并评价其性质。方法:以阿苯达唑-PEG固体分散体(ASD)为主体,壳聚糖为载体,采用乳化交联法制备ASD壳聚糖微球;采用电镜、红外光谱、X衍射分析法等对微球进行表征并考察其药剂学性质;动态透析法研究微球的体外释放特性。结果:所制得微球形态圆整,粒径分布均匀,平均粒径约(210±3.8)μm,载药量(6.42±0.32)%,包封率(57.86±0.74)%;红外光谱、X衍射分析法证明药物成功包载于微球中;微球在醋酸盐溶液(pH3.5)介质中的释放情况遵循Higuchi方程,可持续释放400h以上。结论:本法制备微球工艺稳定,所制微球具有显著的缓释效果。

关 键 词:阿苯达唑  聚乙二醇6000  固体分散体  壳聚糖  微球  制备  体外释放

Study on Preparation and Pharmaceutical Characteristics of Albendazole-PEG6000 Solid Dispersions-chitosan Microspheres
WANG Xiao-qing,LIU Yang,CHEN Yuan-lan,ZHU Ai-jun,ZHANG Guang-yu,ZHANG Xue-nongSchool of Pharmaceutical,Soochow University Medical Center,Jiangsu Suzhou,China REN Wei-xin,Dilimulati·Bawudong,GU Jun-peng,XU Xiao-dong.Study on Preparation and Pharmaceutical Characteristics of Albendazole-PEG6000 Solid Dispersions-chitosan Microspheres[J].China Pharmacy,2012(5):424-427.
Authors:WANG Xiao-qing  LIU Yang  CHEN Yuan-lan  ZHU Ai-jun  ZHANG Guang-yu  ZHANG Xue-nongSchool of Pharmaceutical  Soochow University Medical Center  Jiangsu Suzhou  China REN Wei-xin  Dilimulati·Bawudong  GU Jun-peng  XU Xiao-dong
Affiliation:(The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China)
Abstract:OBJECTIVE:To prepare Albendazole-PEG6000 solid dispersions(ASD)-chitosan microspheres,and to evaluate the property of it.METHODS:ASD chitosan microspheres were prepared by emulsion cross-linking technique using ASD as main component and chitosan as carrier.Superficial characteristics and pharmaceutical property of microspheres were investigated by electronic microscope,IR-spectrum and X-ray diffraction.Dynamic dialysis system was adopted to study the drug release in vitro.RESULTS:The microspheres were spherical in shape and even in particle size.The mean diameter was(210±3.8) μm.The drug-loading amount and encapsulated efficiency of microspheres were(6.42±0.32)% and(57.86±0.74)%.IR-spectrum and X-ray diffraction indicated drug had been included in microspheres successfully.The release behavior of ABZ-PEG6000-CS-MS in acetate was in line with Higuchi model lasting for more than 400 h.CONCLUSION:The optimized technology presents good stability and excellent effect of sustained drug release.
Keywords:Albendazole  PEG6000  Solid dispersions  Chitosan  Microspheres  Preparation  In vitro release
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号